Commonwealth slams Otsuka’s ‘inconsistent’ defences in Abilify patent case

Allens 2018-12-10 10:02 pm By Miklos Bolza | Sydney

Please login to bookmark

The Commonwealth has urged the court to strike out the “inconsistent” pleadings of pharmaceutical firms Otsuka and Bristol-Myers Squibb in a patent case over the antipsychotic drug Abilify, calling them a “scandal” which could bring disrepute to the administration of justice.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au